Cargando…

Ubiquitination of ASCL1 mediates CD47 transcriptional activation of the AKT signaling pathway, and glycolysis promotes osteogenic differentiation of hBMSCs

Bones are extremely dynamic organs that continually develop and remodel. This process involves changes in numerous gene expressions. hBMSC cells can promote osteogenic differentiation. The purpose of this study was to elucidate the mechanism by which ASCL1 promotes osteogenic differentiation in hBMS...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jimei, Zhu, Ling, Zhou, Jianping, Yu, Qunying, Yang, Guangyuan, Zhao, Ke, Luo, Chaoli, Meng, Jianguo, Liu, Jing, Yang, Xuming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567835/
https://www.ncbi.nlm.nih.gov/pubmed/37783914
http://dx.doi.org/10.1007/s11626-023-00811-0
_version_ 1785119223385686016
author Zhang, Jimei
Zhu, Ling
Zhou, Jianping
Yu, Qunying
Yang, Guangyuan
Zhao, Ke
Luo, Chaoli
Meng, Jianguo
Liu, Jing
Yang, Xuming
author_facet Zhang, Jimei
Zhu, Ling
Zhou, Jianping
Yu, Qunying
Yang, Guangyuan
Zhao, Ke
Luo, Chaoli
Meng, Jianguo
Liu, Jing
Yang, Xuming
author_sort Zhang, Jimei
collection PubMed
description Bones are extremely dynamic organs that continually develop and remodel. This process involves changes in numerous gene expressions. hBMSC cells can promote osteogenic differentiation. The purpose of this study was to elucidate the mechanism by which ASCL1 promotes osteogenic differentiation in hBMSC cells while decreasing glycolysis. hBMSCs were induced to differentiate into osteoblasts. The ASCL1 expression level during hBMSC osteogenic differentiation was measured by RT‒qPCR, Western blotting, and immunofluorescence. The differentiation level of osteoblasts was observed after staining with ALP and alizarin red. ChIP-qPCR were used to determine the relationship between ASCL1 and CD47, and the expression of glycolysis-related proteins was detected. Overexpression of ASCL1 was used to determine its impact on osteogenic differentiation. si-USP8 was used to verify the ubiquitination of ASCL1-mediated CD47/AKT pathway’s impact on hBMSC glycolysis and osteogenic differentiation. The results showed that the expression of ASCL1 was upregulated after the induction of osteogenic differentiation in hBMSCs. From a functional perspective, knocking down USP8 can promote the ubiquitination of ASCL1, while the osteogenic differentiation ability of hBMSCs was improved after the overexpression of ASCL1, indicating that ASCL1 can promote the osteogenic differentiation of hBMSCs. In addition, USP8 regulates the ubiquitination level of ASCL1 and mediates CD47 transcriptional regulation of the AKT pathway to increase the glycolysis level of hBMSCs and cell osteogenic differentiation. USP8 ubiquitination regulates the level of ASCL1. In addition, ubiquitination of ASCL1 mediates CD47 transcription to activate the AKT signaling pathway and increase hBMSC glycolysis to promote osteogenic differentiation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11626-023-00811-0.
format Online
Article
Text
id pubmed-10567835
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-105678352023-10-13 Ubiquitination of ASCL1 mediates CD47 transcriptional activation of the AKT signaling pathway, and glycolysis promotes osteogenic differentiation of hBMSCs Zhang, Jimei Zhu, Ling Zhou, Jianping Yu, Qunying Yang, Guangyuan Zhao, Ke Luo, Chaoli Meng, Jianguo Liu, Jing Yang, Xuming In Vitro Cell Dev Biol Anim Article Bones are extremely dynamic organs that continually develop and remodel. This process involves changes in numerous gene expressions. hBMSC cells can promote osteogenic differentiation. The purpose of this study was to elucidate the mechanism by which ASCL1 promotes osteogenic differentiation in hBMSC cells while decreasing glycolysis. hBMSCs were induced to differentiate into osteoblasts. The ASCL1 expression level during hBMSC osteogenic differentiation was measured by RT‒qPCR, Western blotting, and immunofluorescence. The differentiation level of osteoblasts was observed after staining with ALP and alizarin red. ChIP-qPCR were used to determine the relationship between ASCL1 and CD47, and the expression of glycolysis-related proteins was detected. Overexpression of ASCL1 was used to determine its impact on osteogenic differentiation. si-USP8 was used to verify the ubiquitination of ASCL1-mediated CD47/AKT pathway’s impact on hBMSC glycolysis and osteogenic differentiation. The results showed that the expression of ASCL1 was upregulated after the induction of osteogenic differentiation in hBMSCs. From a functional perspective, knocking down USP8 can promote the ubiquitination of ASCL1, while the osteogenic differentiation ability of hBMSCs was improved after the overexpression of ASCL1, indicating that ASCL1 can promote the osteogenic differentiation of hBMSCs. In addition, USP8 regulates the ubiquitination level of ASCL1 and mediates CD47 transcriptional regulation of the AKT pathway to increase the glycolysis level of hBMSCs and cell osteogenic differentiation. USP8 ubiquitination regulates the level of ASCL1. In addition, ubiquitination of ASCL1 mediates CD47 transcription to activate the AKT signaling pathway and increase hBMSC glycolysis to promote osteogenic differentiation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11626-023-00811-0. Springer US 2023-10-02 2023 /pmc/articles/PMC10567835/ /pubmed/37783914 http://dx.doi.org/10.1007/s11626-023-00811-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Zhang, Jimei
Zhu, Ling
Zhou, Jianping
Yu, Qunying
Yang, Guangyuan
Zhao, Ke
Luo, Chaoli
Meng, Jianguo
Liu, Jing
Yang, Xuming
Ubiquitination of ASCL1 mediates CD47 transcriptional activation of the AKT signaling pathway, and glycolysis promotes osteogenic differentiation of hBMSCs
title Ubiquitination of ASCL1 mediates CD47 transcriptional activation of the AKT signaling pathway, and glycolysis promotes osteogenic differentiation of hBMSCs
title_full Ubiquitination of ASCL1 mediates CD47 transcriptional activation of the AKT signaling pathway, and glycolysis promotes osteogenic differentiation of hBMSCs
title_fullStr Ubiquitination of ASCL1 mediates CD47 transcriptional activation of the AKT signaling pathway, and glycolysis promotes osteogenic differentiation of hBMSCs
title_full_unstemmed Ubiquitination of ASCL1 mediates CD47 transcriptional activation of the AKT signaling pathway, and glycolysis promotes osteogenic differentiation of hBMSCs
title_short Ubiquitination of ASCL1 mediates CD47 transcriptional activation of the AKT signaling pathway, and glycolysis promotes osteogenic differentiation of hBMSCs
title_sort ubiquitination of ascl1 mediates cd47 transcriptional activation of the akt signaling pathway, and glycolysis promotes osteogenic differentiation of hbmscs
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567835/
https://www.ncbi.nlm.nih.gov/pubmed/37783914
http://dx.doi.org/10.1007/s11626-023-00811-0
work_keys_str_mv AT zhangjimei ubiquitinationofascl1mediatescd47transcriptionalactivationoftheaktsignalingpathwayandglycolysispromotesosteogenicdifferentiationofhbmscs
AT zhuling ubiquitinationofascl1mediatescd47transcriptionalactivationoftheaktsignalingpathwayandglycolysispromotesosteogenicdifferentiationofhbmscs
AT zhoujianping ubiquitinationofascl1mediatescd47transcriptionalactivationoftheaktsignalingpathwayandglycolysispromotesosteogenicdifferentiationofhbmscs
AT yuqunying ubiquitinationofascl1mediatescd47transcriptionalactivationoftheaktsignalingpathwayandglycolysispromotesosteogenicdifferentiationofhbmscs
AT yangguangyuan ubiquitinationofascl1mediatescd47transcriptionalactivationoftheaktsignalingpathwayandglycolysispromotesosteogenicdifferentiationofhbmscs
AT zhaoke ubiquitinationofascl1mediatescd47transcriptionalactivationoftheaktsignalingpathwayandglycolysispromotesosteogenicdifferentiationofhbmscs
AT luochaoli ubiquitinationofascl1mediatescd47transcriptionalactivationoftheaktsignalingpathwayandglycolysispromotesosteogenicdifferentiationofhbmscs
AT mengjianguo ubiquitinationofascl1mediatescd47transcriptionalactivationoftheaktsignalingpathwayandglycolysispromotesosteogenicdifferentiationofhbmscs
AT liujing ubiquitinationofascl1mediatescd47transcriptionalactivationoftheaktsignalingpathwayandglycolysispromotesosteogenicdifferentiationofhbmscs
AT yangxuming ubiquitinationofascl1mediatescd47transcriptionalactivationoftheaktsignalingpathwayandglycolysispromotesosteogenicdifferentiationofhbmscs